Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikiProjectMed
Search

Mannitol

This article's lead is ready for translation. Click for more information.
From WikiProjectMed

d-Mannitol
Names
Trade namesOsmitrol, other
Other namesd-Mannitol, mannite, manna sugar
  • (2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
Clinical data
Drug classOsmotic diuretic[1]
Main usesSweetener,glaucoma,increased intracranial pressure[2][3][4]
Side effectsElectrolyte problems,dehydration[1]
Pregnancy
category
Routes of
use
intravenous
by mouth
Defined daily dose0.8 g[5]
External links
AHFS/Drugs.comMonograph
Legal
License data
Pharmacokinetics
Bioavailability~7%
MetabolismLiver, negligible
Eliminationhalf-life100 minutes
ExcretionKidney: 90%
Chemical and physical data
FormulaC6H14O6
Molar mass182.172 g·mol−1
3D model (JSmol)
  • O[C@H]([C@H](O)CO)[C@H](O)[C@H](O)CO
  • InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1 checkY
  • Key:FBPFZTCFMRRESA-KVTDHHQDSA-N checkY

Mannitol is a type ofsugar alcohol used as asweetener and medication.[2][4] As a sweetener it is used indiabetic food as it is poorly absorbed by theintestines.[2] As a medication, it is used to decrease pressure in the eyes, as inglaucoma, and to lowerincreased intracranial pressure.[3][4] Medically, it is given by injection.[1] Effects typically begin within 15 minutes and last up to 8 hours.[1]

Common side effects from medical use includeelectrolyte problems anddehydration.[1] Other serious side effects may include worseningheart failure andkidney problems.[1][4] It is unclear if use is safe inpregnancy.[1] Mannitol is in theosmotic diuretic family of medications and works by pulling fluid from the brain and eyes.[1]

The discovery of mannitol is attributed toJoseph Louis Proust in 1806.[6] It is on theWorld Health Organization's List of Essential Medicines.[7] The wholesale cost in thedeveloping world is about 1.12 to US$5.80 per dose.[8] In the United States, a course of treatment costs $25 to $50.[9] It was originally made from theflowering ash and calledmanna due to its supposed resemblance to the Biblical food.[10][11] Mannitol is on theWorld Anti-Doping Agency's banned drug list due to concerns that it may mask other drugs.[12]

Uses

Medical uses

Mannitol is used to reduce acutely raised intracranial pressure until more definitive treatment can be applied, e.g., afterhead trauma.

It may also be used for certain cases ofkidney failure with low urine output, decreasingpressure in the eye, to increase the elimination of certain toxins, and to treatfluid build up.[1]

Intraoperative mannitol prior to vessel clamp release during renal transplant has been shown to reduce post-transplant kidney injury, but has not been shown to reduce graft rejection.[medical citation needed]

Mannitol acts as an osmoticlaxative[13] in oral doses larger than 20 g,[14] and is sometimes sold as a laxative for children.[citation needed]

The use of mannitol, when inhaled, as a bronchial irritant as an alternative method of diagnosis ofexercise-induced asthma has been proposed. A 2013 systematic review concluded evidence to support its use for this purpose at this time is insufficient.[15]

Mannitol is commonly used in the circuit prime of aheart lung machine duringcardiopulmonary bypass. The presence of mannitol preserves renal function during the times of low blood flow and pressure, while the patient is on bypass. The solution prevents the swelling ofendothelial cells in the kidney, which may have otherwise reduced blood flow to this area and resulted in cell damage.

Mannitol can also be used to temporarily encapsulate a sharp object (such as a helix on a lead for anartificial pacemaker) while it passes through the venous system. Because the mannitol dissolves readily in blood, the sharp point becomes exposed at its destination.

Mannitol is also the first drug of choice to treat acuteglaucoma in veterinary medicine. It is administered as a 20% solution intravenously. It dehydrates thevitreous humor and, therefore, lowers the intraocular pressure. However, it requires an intact blood-ocular barrier to work.[16]

  • A case of intraoperative mannitol use-A 46-year-old-female with a blowout fracture in the right medial and inferior wall. (A) Preoperative photo with a worm's eye view shows moderate enophthalmos in the involved eye. (B) Two months after the operation, the enophthalmos had been resolved.
    A case of intraoperative mannitol use-A 46-year-old-female with a blowout fracture in the right medial and inferior wall. (A) Preoperative photo with a worm's eye view shows moderate enophthalmos in the involved eye. (B) Two months after the operation, the enophthalmos had been resolved.
  • Mannitol 20% for intravenous use
    Mannitol 20% for intravenous use
  • Mannitol 15% solution for intravenous use
    Mannitol 15% solution for intravenous use

Food

Mannitol increases blood glucose to a lesser extent thansucrose (thus having a relatively lowglycemic index[17]) so is used as asweetener for people withdiabetes, and inchewing gums. Although mannitol has a higherheat of solution than most sugar alcohols, its comparatively low solubility reduces the cooling effect usually found in mint candies and gums. However, when mannitol is completely dissolved in a product, it induces a strong cooling effect.[18] Also, it has a very lowhygroscopicity – it does not pick up water from the air until the humidity level is 98%. This makes mannitol very useful as a coating for hard candies, dried fruits, and chewing gums, and it is often included as an ingredient in candies and chewing gum.[19] The pleasant taste and mouthfeel of mannitol also makes it a popularexcipient for chewable tablets.[20]

Analytical chemistry

Mannitol can be used to form a complex withboric acid. This increases the acid strength of the boric acid, permitting better precision in volumetric analysis of this acid.[21]

Other

Mannitol is the primary ingredient ofmannitol salt agar, a bacterial growth medium, and is used in others.

Mannitol is used as acutting agent[22] in various drugs that are used intranasally (snorted), such ascocaine. A mixture of mannitol andfentanyl (orfentanyl analogs) in ratio 1:10 is labeled and sold as "China white", a popular heroin substitute.[citation needed]

Dosage

Thedefined daily dose is 0.8 gram (inhalation)[5]

Contraindication

Mannitol is contraindicated in people withanuria,congestive heart failure.[citation needed]

Adverse effects include hyponatremia and volume depletion leading to metabolic acidosis.[6]

Chemistry

Mannitol is anisomer ofsorbitol, another sugar alcohol; the two differ only in the orientation of thehydroxyl group on carbon 2.[23] While similar, the two sugar alcohols have very different sources in nature,melting points, and uses.

Production

Mannitol is classified as asugar alcohol; that is, it can be derived from a sugar (mannose) by reduction. Other sugar alcohols includexylitol andsorbitol. Mannitol and sorbitol areisomers, the only difference being the orientation of the hydroxyl group on carbon 2.[18]

Industrial synthesis

Mannitol is commonly produced via thehydrogenation of fructose, which is formed from eitherstarch orsucrose (common table sugar). Although starch is a cheaper source than sucrose, the transformation of starch is much more complicated. Eventually, it yields a syrup containing about 42%fructose, 52%glucose, and 6%maltose.Sucrose is simply hydrolyzed into aninvert sugar syrup, which contains about 50% fructose. In both cases, the syrups are chromatographically purified to contain 90–95% fructose. The fructose is then hydrogenated over a nickelcatalyst into a mixture of isomerssorbitol and mannitol. Yield is typically 50%:50%, although slightlyalkaline reaction conditions can slightly increase mannitol yields.[18]

Biosyntheses

Mannitol is one of the most abundant energy and carbon storage molecules in nature, produced by a plethora of organisms, including bacteria, yeasts, fungi, algae, lichens, and many plants.[24]Fermentation by microorganisms is an alternative to the traditional industrial synthesis. A fructose to mannitolmetabolic pathway, known as the mannitol cycle in fungi, has been discovered in a type of red algae (Caloglossa leprieurii), and it is highly possible that other microorganisms employ similar such pathways.[25] A class oflactic acid bacteria, labeled heterofermentive because of their multiple fermentation pathways, convert either three fructose molecules or two fructose and one glucose molecule into two mannitol molecules, and one molecule each oflactic acid,acetic acid, andcarbon dioxide.Feedstock syrups containing medium to large concentrations of fructose (for example,cashew apple juice, containing 55% fructose: 45%glucose) can produce yields 200 g (7.1 oz) mannitol per liter of feedstock. Further research is being conducted, studying ways to engineer even more efficient mannitol pathways in lactic acid bacteria, as well as the use of other microorganisms such asyeast[24] andE. coli in mannitol production. When food-grade strains of any of the aforementioned microorganisms are used, the mannitol and the organism itself are directly applicable to food products, avoiding the need for careful separation of microorganism and mannitol crystals. Although this is a promising method, steps are needed to scale it up to industrially needed quantities.[25]

Natural extraction

Since mannitol is found in a wide variety of natural products, including almost all plants, it can be directly extracted from natural products, rather than chemical or biological syntheses. In fact, in China, isolation fromseaweed is the most common form of mannitol production.[19] Mannitol concentrations of plantexudates can range from 20% in seaweeds to 90% in theplane tree. It is a constituent of saw palmetto (Serenoa).[26]

Traditionally, mannitol is extracted by theSoxhlet extraction, usingethanol, water, andmethanol to steam and then hydrolysis of the crude material. The mannitol is thenrecrystallized from the extract, generally resulting in yields of about 18% of the original natural product. Another method of extraction is usingsupercritical andsubcritical fluids. These fluids are at such a stage that no difference exists between the liquid and gas stages, so are morediffusive than normal fluids. This is considered to make them much more effective mass transfer agents than normal liquids. The super- or subcritical fluid is pumped through the natural product, and the mostly mannitol product is easily separated from the solvent and minute amount of byproduct.

Supercriticalcarbon dioxide extraction of olive leaves has been shown to require less solvent per measure of leaf than a traditional extraction — 141.7 g (5.00 oz) CO2 versus 194.4 g (6.86 oz) ethanol per 1 g (0.035 oz) olive leaf. Heated, pressurized,subcritical water is even cheaper, and is shown to have dramatically greater results than traditional extraction. It requires only 4.01 g (0.141 oz) water per 1 g (0.035 oz) of olive leaf, and gives a yield of 76.75% mannitol. Both super- and subcritical extractions are cheaper, faster, purer, and more environmentally friendly than the traditional extraction. However, the required high operating temperatures and pressures are causes for hesitancy in the industrial use of this technique.[25]

History

Julije Domac elucidated the structure ofhexene and mannitol obtained fromCaspian manna. He determined the place of the double bond in hexene obtained from mannitol and proved that it is a derivative of a normalhexene. This also solved the structure of mannitol, which was unknown until then.[27][28][29][30]

Controversy

The three studies[31][32][33] that initially found that high-dose mannitol was effective in cases of severe head injury were the subject of an investigation published in 2007.[34] Although several authors are listed with Dr. Julio Cruz, it is unclear whether the authors had knowledge of how the patients were recruited. Further, the Federal University of São Paulo, which Dr. Cruz gave as his affiliation, has never employed him. As a result of doubt surrounding Cruz's work, an updated version of theCochrane review excludes all studies by Julio Cruz, leaving only 4 studies.[3] Due to differences in selection of control groups, a conclusion about the clinical use of mannitol could not be reached.

Compendial status

See also

References

  1. 1.01.11.21.31.41.51.61.71.8"Mannitol". The American Society of Health-System Pharmacists.Archived from the original on 26 May 2015. Retrieved8 January 2015.Archived 26 May 2015 at theWayback Machine
  2. 2.02.12.2Varzakas, Theodoros; Labropoulos, Athanasios; Anestis, Stylianos (2012).Sweeteners: Nutritional Aspects, Applications, and Production Technology. CRC Press. pp. 59–60.ISBN 9781439876732.Archived from the original on 10 September 2017.
  3. 3.03.13.2Wakai A, McCabe A, Roberts I, Schierhout G (August 2013)."Mannitol for acute traumatic brain injury".The Cochrane Database of Systematic Reviews.8 (8): CD001049.doi:10.1002/14651858.CD001049.pub5.PMC 7050611.PMID 23918314.
  4. 4.04.14.24.3World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.).WHO Model Formulary 2008. World Health Organization. p. 332.hdl:10665/44053.ISBN 9789241547659.
  5. 5.05.1"WHOCC - ATC/DDD Index".www.whocc.no.Archived from the original on 16 May 2021. Retrieved19 September 2020.Archived 16 May 2021 at theWayback Machine
  6. 6.06.1Kremers, Edward; Sonnedecker, Glenn (1986).Kremers and Urdang's History of Pharmacy. Amer. Inst. History of Pharmacy. p. 360.ISBN 9780931292170.Archived from the original on 10 September 2017.
  7. World Health Organization (2019).World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization.hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  8. "Mannitol".International Drug Price Indicator Guide.Archived from the original on 7 July 2018. Retrieved8 December 2016.Archived 7 July 2018 at theWayback Machine
  9. Hamilton, Richart (2015).Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 344.ISBN 9781284057560.
  10. Cottrell, James E.; Patel, Piyush (2016).Cottrell and Patel's Neuroanesthesia. Elsevier Health Sciences. p. 160.ISBN 9780323461122.Archived from the original on 10 September 2017. Retrieved4 September 2017.
  11. Bardal, Stan; Waechter, Jason; Martin, Doug (2010).Applied Pharmacology. Elsevier Health Sciences. p. 411.ISBN 978-1437735789.Archived from the original on 10 September 2017. Retrieved4 September 2017.
  12. "THE 2017 PROHIBITED LIST INTERNATIONAL STANDARD"(PDF). January 2017. p. 5.Archived(PDF) from the original on 22 April 2018. Retrieved7 July 2018.Archived 22 April 2018 at theWayback Machine
  13. "Select Committee on GRAS Substances (SCOGS) Opinion: Mannitol".FDA.gov. April 2013.Archived from the original on 22 October 2014.Archived 22 October 2014 at theWayback Machine
  14. Ellis FW, Krantz JC (1941)."Sugar alcohols: XXII. Metabolism and toxicity studies with mannitol and sorbitol in man and animals".J. Biol. Chem.141:147–154.Archived from the original on 10 September 2017.Archived 10 September 2017 at theWayback Machine
  15. Stickland MK, Rowe BH, Spooner CH, Vandermeer B, Dryden DM (September 2011). "Accuracy of eucapnic hyperpnea or mannitol to diagnose exercise-induced bronchoconstriction: a systematic review".Annals of Allergy, Asthma & Immunology.107 (3): 229–34.e8.doi:10.1016/j.anai.2011.06.013.PMID 21875541.
  16. Veterinary Class Notes, Ophthalmology, The Ohio State University, provided by David Wilkie, DVM, DACVO
  17. Grenby TH (2011).Advances in Sweeteners. Springer. p. 66.ISBN 978-1461285229.
  18. 18.018.118.2Kearsley MW, Deis RC (2006). "Sorbitol and Mannitol".Sweeteners and Sugar Alternatives in Food Technology. Wiley-Blackwell. pp. 249–261.ISBN 0470659688.
  19. 19.019.1Lawson P (2007).Mannitol. Blackwell Publishing Ltd. pp. 219–225.
  20. Weiner, Myra L.; Kotkoskie, Lois A. (1999).Excipient Toxicity and Safety. pp. 370.ISBN 9780824782108.
  21. Belcher R, Nutten AJ (1960).Quantitative Inorganic Analysis (2nd ed.). London, UK: Butterworths. p. 194.
  22. "Cut the Shit". December 2005.Archived from the original on 27 September 2016. Retrieved4 September 2017.Archived 27 September 2016 at theWayback Machine
  23. Kearsley MW, Deis RC (2006). "Sorbitol and Mannitol".Sweeteners and Sugar Alternatives in Food Technology. Ames: Oxford. pp. 249–261.{{cite book}}: CS1 maint: location missing publisher (link)
  24. 24.024.1Song SH, Vieille C (August 2009). "Recent advances in the biological production of mannitol".Applied Microbiology and Biotechnology.84 (1):55–62.doi:10.1007/s00253-009-2086-5.PMID 19578847.
  25. 25.025.125.2Ghoreishi SM, Shahrestani RG (2009). "Innovative strategies for engineering mannitol production".Trends in Food Science & Technology.20 (6–7):263–270.doi:10.1016/j.tifs.2009.03.006.
  26. Wagner H, Flachsbarth H, Vogel G (March 1981). "[A New Antiphlogistic Principle from Sabal serrulata, II]".Planta Medica.41 (3):252–8.doi:10.1055/s-2007-971711.PMID 17401849.
  27. Inić S, Kujundžić N (2011). "The first independent pharmacognosy institute in the world and its founder Julije Domac (1853–1928)".Die Pharmazie.66 (6):720–726.
  28. Domac J (1881). "Über das Hexylen aus Mannit".Sitzungsberichte der Kaiserlichen Akademie der Wissenschaften, Mathematisch-Naturwissenschaftliche Classe.23:1038–1051.
  29. Domac J (1881). "Über das Hexylen aus Mannit".Monatshefte für Chemie.2:309–322.doi:10.1007/BF01516516.
  30. Domac J (1882)."II. Ueber die Einwirkung der Unterchlorsäure auf Hexylen".Justus Liebig's Annalen der Chemie.213:124–132.doi:10.1002/jlac.18822130107.Archived from the original on 21 September 2020. Retrieved16 January 2020.Archived 21 September 2020 at theWayback Machine
  31. Cruz J, Minoja G, Okuchi K (October 2001). "Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial".Neurosurgery.49 (4):864–71.doi:10.1097/00006123-200110000-00016.PMID 11564247.
  32. Cruz J, Minoja G, Okuchi K (September 2002). "Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial".Neurosurgery.51 (3):628–37, discussion 637–8.doi:10.1097/00006123-200209000-00006.PMID 12188940.
  33. Cruz J, Minoja G, Okuchi K, Facco E (March 2004). "Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial".Journal of Neurosurgery.100 (3):376–83.doi:10.3171/jns.2004.100.3.0376.PMID 15035271.
  34. Roberts I, Smith R, Evans S (February 2007)."Doubts over head injury studies".BMJ.334 (7590):392–4.doi:10.1136/bmj.39118.480023.BE.PMC 1804156.PMID 17322250.
  35. British Pharmacopoeia Commission Secretariat (2009)."Index, BP 2009"(PDF). Archived fromthe original(PDF) on 11 April 2009. Retrieved31 January 2010.Archived 11 April 2009 at theWayback Machine
  36. "Japanese Pharmacopoeia, Fifteenth Edition"(PDF). 2006. Archived fromthe original(PDF) on 22 July 2011. Retrieved31 January 2010.Archived 22 July 2011 at theWayback Machine
  37. USP 32 (2008)."Mannitol Injection"(PDF). Archived fromthe original(PDF) on 6 July 2010. Retrieved31 January 2010.{{cite web}}: CS1 maint: numeric names: authors list (link)Archived 6 July 2010 at theWayback Machine

External links

External sites:
Identifiers:
By consumption
Alcohols found in
alcoholic drinks
Medical alcohol
Toxic alcohols
Primary
alcohols
(1°)
Methanol
Ethanol
Butanol
Straight-chain
saturated
C1 — C9
Straight-chain
saturated
C10 — C19
Straight-chain
saturated
C20 — C29
Straight-chain
saturated
C30 — C39
Straight-chain
saturated
C40 — C49
Secondary
alcohols (2°)
Tertiary
alcohols (3°)
Hydric alcohols
Monohydric alcohols
Dihydric alcohols
Trihydric alcohols
Amyl alcohols
Aromatic alcohols
Branched and
unsaturated
fatty alcohols
Sugar alcohols
C2 — C7
Deoxy sugar
alcohols
Cyclic sugar
alcohols
Glycylglycitols
Terpene alcohols
Monoterpene
alcohol
Diterpene
alcohols
Dialcohols
Fluoroalcohols
Preparations
Reactions
Drugs for constipation (laxatives andcathartics) (A06)
Stool softeners
Stimulant laxatives
Bulk-forming laxatives
Lubricant laxatives
Osmotic laxatives
Enemas
Opioid antagonists
Others
Blood substitutes and perfusion solutions (B05)
Blood and related products (B05A)
Intravenous solutions (B05B)
Irrigating solutions (B05C)
Others (B05D, B05X)
Expectorants
Mucolytics
Cough suppressants
Opium alkaloids,
opioids,
and derivatives
Other

Retrieved from "https://mdwiki.org/w/index.php?title=Mannitol&oldid=1468180"
Categories:

[8]ページ先頭

©2009-2025 Movatter.jp